Bawik, Natividad V.
HRN: 25-30-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/21/2024
06/28/2024
IV INFUSION
2 25gm
Q8H
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes